Holen Sie sich die Stockscreener-App
0.8204
1.08%
0.0088
Handel nachbörslich:
.81
-0.0104
-1.27%
Schlusskurs vom Vortag:
$0.8116
Offen:
$0.806201
24-Stunden-Volumen:
76,147
Relative Volume:
0.64
Marktkapitalisierung:
$6.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.059
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
+6.61%
1M Leistung:
+6.50%
6M Leistung:
-31.06%
1J Leistung:
-82.58%
1-Tages-Spanne:
$0.8009
$0.83
1-Wochen-Bereich:
$0.75
$0.84
52-Wochen-Spanne:
$0.65
$5.00
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.8204 | 6.04M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastFederal Reserve Announcements & Get Tomorrow’s Winners Today With AI - earlytimes.in
What recovery options are there for Pasithea Therapeutics Corp.Product Launch & Free Community Supported Trade Ideas - newser.com
Is a relief rally coming for Pasithea Therapeutics Corp. Equity Warrant holdersJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Real time breakdown of Pasithea Therapeutics Corp. stock performanceMarket Risk Analysis & High Conviction Investment Ideas - newser.com
What risks investors should watch in Pasithea Therapeutics Corp. stockMarket Risk Analysis & Fast Moving Trade Plans - newser.com
Pasithea Therapeutics Corp. stock daily chart insights2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Will Pasithea Therapeutics Corp. stock maintain dividend yield2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Is it time to cut losses on Pasithea Therapeutics Corp.July 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Using R and stats models for Pasithea Therapeutics Corp. forecasting2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
How Pasithea Therapeutics Corp. stock responds to policy changesJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Can technical indicators confirm Pasithea Therapeutics Corp. Equity Warrant’s reversalJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Trend analysis for Pasithea Therapeutics Corp. this weekWall Street Watch & Weekly Top Stock Performers List - newser.com
What Makes Three M Paper Boards Limited Stand Out Among CompetitorsVolume Weighted Average Price & Maximum Profit Growth - earlytimes.in
Using Bollinger Bands to evaluate Pasithea Therapeutics Corp.2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Tick level data insight on Pasithea Therapeutics Corp. volatilityGDP Growth & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp. Equity Warrant2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Pasithea Therapeutics Corp. stock trendline breakdownWeekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Pasithea Therapeutics (NASDAQ:KTTA) Shares Up 2.5% – Here’s Why - Defense World
How currency fluctuations impact Pasithea Therapeutics Corp. stock2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com
What to expect from Pasithea Therapeutics Corp. in the next 30 days2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Pasithea Therapeutics Corp. stock rebound after recent weakness - newser.com
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):